AI-powered
pharmacovigilance
automation for
global and local
literature
monitoring and regulatory intelligence.
Streamline your drug safety routines with us
Our customers
Pharmacovigilance evolving rapidly.
We understand your pressures
the industry
Growth has slowed down as new aggressive entrants with AI-tech shake the status quo.
New heavy investments have longer paybacks while the change cycles have shrinked.
The number of audits has increased. More and more non-compliance cases and mitigations.
Good people leaving increases the retention costs, while the new talent costs more. Heavy investments in staff training and onboarding new talents.
and harder
People are stressed and it is hard to predict their buying behaviors. Adverse reactions become more frequent.
Entering new markets has become longer, less predictable, and more costly.
Global pressures dictate new requirements to drug safety processes
- Continuous and regular
- Traceable and transparent
- Accurate, complete, holistic
- Scalable to new markets
- Multi-language
- Multi-region suppliers
- CAPEX free investments
- Cost-effective
About DrugCard platform in numbers
Supported by DrugCard
Medical journals coverage
Countiniously monitored
Compared to human-only approach
Our Management Team
DrugCard solution designed for
When pharma outsource PV processes to CROs, they expect the highest quality and maximum search results to ensure full compliance with regulatory requirements. CROs can no longer guarantee the best results if they continue to read journals from cover to cover manually. Progressive CROs continuously discover innovative methods and tools to make their pharma customers fully compliant and satisfied.
Outsourcing of literature screening to CROs has become so widespread and common in the last 5-7 years. However, we at DrugCard strongly believe that literature screening could be done more effectively, either in-house, at both a global and local level, or with very few contractors. Managing multiple CROs across several countries is becoming a nightmare for any MAH, creating compliance and reputation risks. DrugCard, its trusted partners, and loyal customers actively promote upgrading obsolete screening practices and help install new standards, high-performance screening methodology, and tools.
With DrugCard, freelancers providing literature screening and other outsourcing services can save up to 70% of their precious time and use it for other value-adding activities such as consulting, research, quality assurance, etc. Higher productivity, less work, more revenues!
Testimonials
